Reported 2 days ago
The Trump administration has canceled a substantial contract with Moderna aimed at the late-stage development of its bird flu vaccine for humans, alongside the option for the government to purchase doses. Initially supported by $590 million from the Biden administration and an additional $176 million from the U.S. Department of Health and Human Services, the project faced scrutiny and was deemed to not meet federal standards for continued investment. This decision raises concerns about public health preparedness as bird flu continues to pose risks.
Source: YAHOO